These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 37065701)
21. Gypenosides Altered Hepatic Bile Acids Homeostasis in Mice Treated with High Fat Diet. Lu Y; Du Y; Qin L; Wu D; Wang W; Ling L; Ma F; Ling H; Yang L; Wang C; Wang Z; Zhou X; He Y Evid Based Complement Alternat Med; 2018; 2018():8098059. PubMed ID: 30105069 [TBL] [Abstract][Full Text] [Related]
22. Analysis of bioactive components and synergistic action mechanism of ShuGan-QieZhi Capsule for treating non-alcoholic fatty liver disease. Zhu T; Huang X; Zhu H; Chen J; Yao H; Zhang Y; Hua H; Zhang J; Qi J Phytomedicine; 2024 Jan; 123():155173. PubMed ID: 37976695 [TBL] [Abstract][Full Text] [Related]
23. Fish oil alleviated high-fat diet-induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study. Yuan F; Wang H; Tian Y; Li Q; He L; Li N; Liu Z Lipids Health Dis; 2016 Feb; 15():20. PubMed ID: 26832365 [TBL] [Abstract][Full Text] [Related]
24. Psoralea corylifolia L. extract ameliorates nonalcoholic fatty liver disease in free-fatty-acid-incubated HEPG2 cells and in high-fat diet-fed mice. Hong Y; Choi SI; Hong E; Kim GH J Food Sci; 2020 Jul; 85(7):2216-2226. PubMed ID: 32579753 [TBL] [Abstract][Full Text] [Related]
25. Cholic acid supplementation accelerates the progression of nonalcoholic fatty liver disease to the procarcinogenic state in mice fed a high-fat and high-cholesterol diet. Chun HJ; Shim YJ; Kwon YH J Nutr Biochem; 2022 Feb; 100():108869. PubMed ID: 34563665 [TBL] [Abstract][Full Text] [Related]
26. Amelioration of hepatic steatosis is associated with modulation of gut microbiota and suppression of hepatic miR-34a in Jia N; Lin X; Ma S; Ge S; Mu S; Yang C; Shi S; Gao L; Xu J; Bo T; Zhao J Nutr Metab (Lond); 2018; 15():86. PubMed ID: 30555521 [TBL] [Abstract][Full Text] [Related]
27. Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice. Hong Y; Sheng L; Zhong J; Tao X; Zhu W; Ma J; Yan J; Zhao A; Zheng X; Wu G; Li B; Han B; Ding K; Zheng N; Jia W; Li H Gut Microbes; 2021; 13(1):1-20. PubMed ID: 34125646 [TBL] [Abstract][Full Text] [Related]
28. JianPi-QingHua formula attenuates nonalcoholic fatty liver disease by regulating the AMPK/SIRT1/NF-κB pathway in high-fat-diet-fed C57BL/6 mice. Tian J; Cai M; Jin S; Chen Q; Xu J; Guo Q; Yan Z; Han X; Lu H Pharm Biol; 2023 Dec; 61(1):647-656. PubMed ID: 37038833 [TBL] [Abstract][Full Text] [Related]
29. Effects of heat-processed Gynostemma pentaphyllum on high-fat diet-fed mice of obesity and functional analysis on network pharmacology and molecular docking strategy. Xie P; Guo M; Xie JB; Xiao MY; Qi YS; Duan Y; Li FF; Piao XL J Ethnopharmacol; 2022 Aug; 294():115335. PubMed ID: 35513215 [TBL] [Abstract][Full Text] [Related]
30. Efficacy of Sitagliptin on Nonalcoholic Fatty Liver Disease in High-fat-diet-fed Diabetic Mice. Zhou ST; Cui W; Kong L; Yang X Curr Med Sci; 2022 Jun; 42(3):513-519. PubMed ID: 35451807 [TBL] [Abstract][Full Text] [Related]
31. Proteomic analysis of the effect of high-fat-diet and voluntary physical activity on mouse liver. So B; Ji LL; Imdad S; Kang C PLoS One; 2022; 17(8):e0273049. PubMed ID: 35981048 [TBL] [Abstract][Full Text] [Related]
32. Gypenosides counteract hepatic steatosis and intestinal barrier injury in rats with metabolic associated fatty liver disease by modulating the adenosine monophosphate activated protein kinase and Toll-like receptor 4/nuclear factor kappa B pathways. Shen S; Wang K; Zhi Y; Dong Y Pharm Biol; 2022 Dec; 60(1):1949-1959. PubMed ID: 36205541 [TBL] [Abstract][Full Text] [Related]
33. Silybin ameliorates hepatic lipid accumulation and modulates global metabolism in an NAFLD mouse model. Sun R; Xu D; Wei Q; Zhang B; Aa J; Wang G; Xie Y Biomed Pharmacother; 2020 Mar; 123():109721. PubMed ID: 31865143 [TBL] [Abstract][Full Text] [Related]
34. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice. Lee MR; Yang HJ; Park KI; Ma JY Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424 [TBL] [Abstract][Full Text] [Related]
35. Effects of calycosin against high-fat diet-induced nonalcoholic fatty liver disease in mice. Duan X; Meng Q; Wang C; Liu Z; Sun H; Huo X; Sun P; Ma X; Peng J; Liu K J Gastroenterol Hepatol; 2018 Feb; 33(2):533-542. PubMed ID: 28699662 [TBL] [Abstract][Full Text] [Related]
36. Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis. Yin X; Liu Z; Wang J Phytomedicine; 2023 Oct; 119():155005. PubMed ID: 37562090 [TBL] [Abstract][Full Text] [Related]
37. Icariin Alleviates Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome by Improving Liver Fatty Acid Oxidation and Inhibiting Lipid Accumulation. Hai Y; Zuo L; Wang M; Zhang R; Wang M; Ren L; Yang C; Wang J Molecules; 2023 Jan; 28(2):. PubMed ID: 36677577 [TBL] [Abstract][Full Text] [Related]
38. Hepatic transcriptome delineates the therapeutic effects of Sanren Tang on high-fat diet-induced non-alcoholic fatty liver disease. Yixiao Y; Hao T; Yi F; Wei L; Jun W; Yiyang HU; Jinghua P J Tradit Chin Med; 2023 Oct; 43(6):1092-1102. PubMed ID: 37946471 [TBL] [Abstract][Full Text] [Related]
39. Schizandrin A supplementation improves nonalcoholic fatty liver disease in mice fed a high-fat and high-cholesterol diet. Jeong MJ; Kim SR; Jung UJ Nutr Res; 2019 Apr; 64():64-71. PubMed ID: 30802724 [TBL] [Abstract][Full Text] [Related]
40. Liver Lipidomics Analysis Revealed the Novel Ameliorative Mechanisms of L-Carnitine on High-Fat Diet-Induced NAFLD Mice. Sun C; Guo Y; Cong P; Tian Y; Gao X Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986087 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]